Case Characteristics, Hyperacute Treatment, and Outcome Information from the Clinical Research Center for Stroke-Fifth Division Registry in South Korea

Characteristics of stroke cases, acute stroke care, and outcomes after stroke differ according to geographical and cultural background. To provide epidemiological and clinical data on stroke care in South Korea, we analyzed a prospective multicenter clinical stroke registry, the Clinical Research Center for Stroke-Fifth Division (CRCS-5). Patients were 58% male with a mean age of 67.2±12.9 years and median National Institutes of Health Stroke Scale score of 3 [1-8] points. Over the 6 years of operation, temporal trends were documented including increasing utilization of recanalization treatment with shorter onset-to-arrival delay and decremental length of stay. Acute recanalization treatment was performed in 12.7% of cases with endovascular treatment utilized in 36%, but the proportion of endovascular recanalization varied across centers. Door-to-IV alteplase delay had a median of 45 [33-68] min. The rate of symptomatic hemorrhagic transformation (HT) was 7%, and that of any HT was 27% among recanalization-treated cases. Early neurological deterioration occurred in 15% of cases and were associated with longer length of stay and poorer 3-month outcomes. The proportion of mRS scores of 0-1 was 42% on discharge, 50% at 3 months, and 55% at 1 year after the index stroke. Recurrent stroke up to 1 year occurred in 4.5% of patients; the rate was higher among older individuals and those with neurologically severe deficits. The above findings will be compared with other Asian and US registry data in this article.

[1]  The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. , 1988, Journal of clinical epidemiology.

[2]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[3]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[4]  Physical disability after stroke in the Perth Community Stroke Study. , 1990, Clinical and experimental neurology.

[5]  C. Anderson,et al.  Long-term risk of first recurrent stroke in the Perth Community Stroke Study. , 1998, Stroke.

[6]  W. O'Fallon,et al.  Survival and recurrence after first cerebral infarction , 1998, Neurology.

[7]  W M O'Fallon,et al.  Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. , 2000, Stroke.

[8]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[9]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[10]  C. Wolfe,et al.  Cause of Stroke Recurrence Is Multifactorial: Patterns, Risk Factors, and Outcomes of Stroke Recurrence in the South London Stroke Register , 2003, Stroke.

[11]  S. Kazui,et al.  Analysis of 16,922 Patients with Acute Ischemic Stroke and Transient Ischemic Attack in Japan , 2004, Cerebrovascular Diseases.

[12]  P. Rothwell,et al.  Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies , 2004, Neurology.

[13]  C. Sudlow,et al.  Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. , 2005, Brain : a journal of neurology.

[14]  Christian Weimar,et al.  Neurologic worsening during the acute phase of ischemic stroke. , 2005, Archives of neurology.

[15]  Deepak L. Bhatt,et al.  The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. , 2006, American heart journal.

[16]  J. Roh,et al.  International experience in stroke registries: Korean Stroke Registry. , 2006, American journal of preventive medicine.

[17]  R. Sacco,et al.  Recurrent stroke and cardiac risks after first ischemic stroke , 2006, Neurology.

[18]  K. Yu,et al.  Impact of neurological and medical complications on 3‐month outcomes in acute ischaemic stroke , 2008, European journal of neurology.

[19]  P. Koudstaal,et al.  Patients Enrolled in Large Randomized Clinical Trials of Antiplatelet Treatment for Prevention After Transient Ischemic Attack or Ischemic Stroke Are Not Representative of Patients in Clinical Practice: The Netherlands Stroke Survey , 2009, Stroke.

[20]  Adrian F Hernandez,et al.  Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. , 2009, American heart journal.

[21]  A-ChingChao,et al.  Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients , 2010 .

[22]  N. Dreyer,et al.  Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .

[23]  Eric E. Smith,et al.  Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010, Circulation. Cardiovascular quality and outcomes.

[24]  A. Rabinstein.  Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010 .

[25]  J. Jeng,et al.  Get With The Guidelines-Stroke Performance Indicators: Surveillance of Stroke Care in the Taiwan Stroke Registry: Get With The Guidelines-Stroke in Taiwan , 2010, Circulation.

[26]  Liping Liu,et al.  The China National Stroke Registry for Patients with Acute Cerebrovascular Events: Design, Rationale, and Baseline Patient Characteristics , 2011, International journal of stroke : official journal of the International Stroke Society.

[27]  C. Yancy,et al.  The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. , 2011, Circulation.

[28]  Hao Li,et al.  Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China: Analysis of the Results From the Chinese National Stroke Registry (CNSR) , 2011, Stroke.

[29]  Gregory W Albers,et al.  Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial , 2012, The Lancet.

[30]  A. Qureshi,et al.  National Trends in Utilization and Outcomes of Endovascular Treatment of Acute Ischemic Stroke Patients in the Mechanical Thrombectomy Era , 2012, Stroke.

[31]  Eric E. Smith,et al.  Times From Symptom Onset to Hospital Arrival in the Get With The Guidelines–Stroke Program 2002 to 2009: Temporal Trends and Implications , 2012, Stroke.

[32]  A. Qureshi,et al.  Discharge destination as a surrogate for Modified Rankin Scale defined outcomes at 3- and 12-months poststroke among stroke survivors. , 2012, Archives of physical medicine and rehabilitation.

[33]  Geoff Cohen,et al.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial , 2012, The Lancet.

[34]  Y. Béjot,et al.  Poststroke Disposition and Associated Factors in a Population-Based Study: The Dijon Stroke Registry , 2012, Stroke.

[35]  Elad I Levy,et al.  Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial , 2012, The Lancet.

[36]  Yilong Wang,et al.  Gender Differences in 1-Year Clinical Characteristics and Outcomes after Stroke: Results from the China National Stroke Registry , 2013, PloS one.

[37]  Max Wintermark,et al.  A trial of imaging selection and endovascular treatment for ischemic stroke. , 2013, The New England journal of medicine.

[38]  Eric E. Smith,et al.  Temporal Trends in Patient Characteristics and Treatment With Intravenous Thrombolysis Among Acute Ischemic Stroke Patients at Get With the Guidelines–Stroke Hospitals , 2013, Circulation. Cardiovascular quality and outcomes.

[39]  Shotai Kobayashi,et al.  Effects of sex difference on clinical features of acute ischemic stroke in Japan. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[40]  Michael D Hill,et al.  Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. , 2013, The New England journal of medicine.

[41]  M. Chen,et al.  Solitaire Flow Restoration thrombectomy for acute ischemic stroke: retrospective multicenter analysis of early postmarket experience after FDA approval. , 2013, Neurosurgery.

[42]  Michela Ponzio,et al.  Endovascular treatment for acute ischemic stroke. , 2013, The New England journal of medicine.

[43]  Chang Wan Oh,et al.  Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke , 2013, Journal of stroke.

[44]  H. Chiou,et al.  Stroke: Morbidity, Risk Factors, and Care in Taiwan , 2014, Journal of Stroke.

[45]  Yong-Jin Cho,et al.  Current Status of Acute Stroke Management in Korea: A Report on a Multicenter, Comprehensive Acute Stroke Registry , 2014, International journal of stroke : official journal of the International Stroke Society.

[46]  J. Pandian,et al.  Cost of Stroke in Low and Middle Income Countries: A Systematic Review , 2014, International journal of stroke : official journal of the International Stroke Society.

[47]  YimingDeng,et al.  Reduction of Length of Stay and Costs Through the Implementation of Clinical Pathways for Stroke Management in China , 2014 .

[48]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[49]  Andrew W. Correia,et al.  Temporal Trends in the Population Attributable Risk for Cardiovascular Disease: The Atherosclerosis Risk in Communities Study , 2014, Circulation.